NCT00782366View on ClinicalTrials.gov

Predictive Genetic Risk Assessment Trial

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Colon CancerLung CancerAtrial FibrillationDiabetes Type 2ObesityBreast CancerGraves DiseaseOsteoarthritisCeliac DiseaseMyocardial InfarctionProstate Cancer
Interventions
GENETIC

SNP analysis

The patients in the intervention group will obtain genetic risk assessments based on genome-wide association studies.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER